- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
ACTEMRA - 162mg/0.9ml - 4
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AC07 | BioTech | Tocilizumab - 162mg/0.9ml | 8202 | 42115/1 | ACTEMRA | 162mg/0.9ml | 4 | Injectable solution | SC | Omnipharma | Vetter Pharma- Fertigung GmbH & Co KG | Germany | 79,959,812 L.L | 10.71 | E1 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |